{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:33:22Z","timestamp":1791113602121,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Advances in Chronic Kidney Disease"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1053\/j.ackd.2014.01.010","type":"journal-article","created":{"date-parts":[[2014,3,4]],"date-time":"2014-03-04T04:01:17Z","timestamp":1393905677000},"page":"194-199","source":"Crossref","is-referenced-by-count":33,"title":["Treatment of FSGS in Children"],"prefix":"10.1053","volume":"21","author":[{"given":"Christine B.","family":"Sethna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie S.","family":"Gipson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1053\/j.ackd.2014.01.010_bib1","doi-asserted-by":"crossref","first-page":"e907","DOI":"10.1542\/peds.2006-2164","article-title":"Nephrotic syndrome in the first year of life: two thirds of cases are caused by mutations in 4 genes (NPHS1, NPHS2, WT1, and LAMB2)","volume":"119","author":"Hinkes","year":"2007","journal-title":"Pediatrics"},{"issue":"11","key":"10.1053\/j.ackd.2014.01.010_bib2","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1007\/s00467-006-0208-1","article-title":"WT1 and glomerular diseases","volume":"21","author":"Niaudet","year":"2006","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"10.1053\/j.ackd.2014.01.010_bib3","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/ki.2013.93","article-title":"Genetic screening in adolescents with steroid-resistant nephrotic syndrome","volume":"84","author":"Lipska","year":"2013","journal-title":"Kidney Int"},{"issue":"9","key":"10.1053\/j.ackd.2014.01.010_bib4","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1007\/s00467-008-0861-7","article-title":"Low prevalence of NPHS2 mutations in African American children with steroid-resistant nephrotic syndrome","volume":"23","author":"Chernin","year":"2008","journal-title":"Pediatr Nephrol"},{"issue":"5993","key":"10.1053\/j.ackd.2014.01.010_bib5","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1193032","article-title":"Association of trypanolytic ApoL1 variants with kidney disease in African Americans","volume":"329","author":"Genovese","year":"2010","journal-title":"Science"},{"issue":"1","key":"10.1053\/j.ackd.2014.01.010_bib6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2215\/CJN.01700408","article-title":"Very low birth weight is a risk factor for secondary focal segmental glomerulosclerosis","volume":"4","author":"Hodgin","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ackd.2014.01.010_bib7","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2215\/CJN.06100612","article-title":"Association of histologic variants in FSGS clinical trial with presenting features and outcomes","volume":"8","author":"D'Agati","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ackd.2014.01.010_bib8","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s00467-006-0019-4","article-title":"Clinical course of 110 children and adolescents with primary focal segmental glomerulosclerosis","volume":"21","author":"Abrantes","year":"2006","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"10.1053\/j.ackd.2014.01.010_bib9","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s00467-005-2097-0","article-title":"Differential risk of remission and ESRD in childhood FSGS","volume":"21","author":"Gipson","year":"2006","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"10.1053\/j.ackd.2014.01.010_bib10","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1681\/ASN.2004070593","article-title":"Focal and segmental glomerulosclerosis: definition and relevance of a partial remission","volume":"16","author":"Troyanov","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"5 pt 2","key":"10.1053\/j.ackd.2014.01.010_bib11","doi-asserted-by":"crossref","first-page":"54R","DOI":"10.1203\/01.PDR.0000160446.01907.B1","article-title":"NPHS2 (Podocin) mutations in nephrotic syndrome. Clinical spectrum and fine mechanisms","volume":"57","author":"Caridi","year":"2005","journal-title":"Pediatr Res"},{"issue":"3","key":"10.1053\/j.ackd.2014.01.010_bib12","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/01.ASN.0000113552.59155.72","article-title":"Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome","volume":"15","author":"Ruf","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"10.1053\/j.ackd.2014.01.010_bib13","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1007\/s004670100021","article-title":"Time trends and ethnic patterns of childhood nephrotic syndrome in Yorkshire, UK","volume":"16","author":"McKinney","year":"2001","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"10.1053\/j.ackd.2014.01.010_bib14","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1542\/peds.2008-1559","article-title":"Management of childhood onset nephrotic syndrome","volume":"124","author":"Gipson","year":"2009","journal-title":"Pediatrics"},{"issue":"2","key":"10.1053\/j.ackd.2014.01.010_bib15","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/ki.1978.23","article-title":"Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. A report of the International Study of Kidney Disease in Children","volume":"13","year":"1978","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.ackd.2014.01.010_bib16","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/ki.1985.29","article-title":"Focal segmental glomerulosclerosis in children with idiopathic nephrotic syndrome. A report of the Southwest Pediatric Nephrology Study Group","volume":"27","year":"1985","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.ackd.2014.01.010_bib17","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/kisup.2012.9","article-title":"KDIGO Clinical Practice Guidelines for glomerulonephritis","volume":"2","year":"2012","journal-title":"Kidney Int Suppl"},{"issue":"5","key":"10.1053\/j.ackd.2014.01.010_bib18","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1007\/s004670050167","article-title":"Cyclophosphamide does not benefit patients with focal segmental glomerulosclerosis. A report of the International Study of Kidney Disease in Children","volume":"10","author":"Tarshish","year":"1996","journal-title":"Pediatr Nephrol"},{"issue":"10","key":"10.1053\/j.ackd.2014.01.010_bib19","first-page":"993","article-title":"Short term efficacy of intravenous dexamethasone and methylprednisolone therapy in steroid resistant nephrotic syndrome","volume":"41","author":"Hari","year":"2004","journal-title":"Indian Pediatr"},{"issue":"8","key":"10.1053\/j.ackd.2014.01.010_bib20","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1093\/ndt\/gfm092","article-title":"Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated","volume":"22","author":"Ehrich","year":"2007","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1053\/j.ackd.2014.01.010_bib21","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1042\/cs0820641","article-title":"Effects of cyclosporin A on glomerular barrier function in the nephrotic syndrome","volume":"82","author":"Zietse","year":"1992","journal-title":"Clin Sci (Lond)"},{"issue":"1","key":"10.1053\/j.ackd.2014.01.010_bib22","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1681\/ASN.V7156","article-title":"A randomized double-blind placebo-controlled trial of cyclosporine in steroid-resistant idiopathic focal segmental glomerulosclerosis in children","volume":"7","author":"Lieberman","year":"1996","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ackd.2014.01.010_bib23","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/ki.1993.194","article-title":"A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome","volume":"43","author":"Ponticelli","year":"1993","journal-title":"Kidney Int"},{"issue":"8","key":"10.1053\/j.ackd.2014.01.010_bib24","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/ki.2011.195","article-title":"Clinical trial of focal segmental glomerulosclerosis in children and young adults","volume":"80","author":"Gipson","year":"2011","journal-title":"Kidney Int"},{"issue":"5","key":"10.1053\/j.ackd.2014.01.010_bib25","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1053\/j.ajkd.2008.11.033","article-title":"Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial","volume":"53","author":"Choudhry","year":"2009","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1053\/j.ackd.2014.01.010_bib26","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00467-003-1370-3","article-title":"Tacrolimus therapy in pediatric patients with treatment-resistant nephrotic syndrome","volume":"19","author":"Loeffler","year":"2004","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"10.1053\/j.ackd.2014.01.010_bib27","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s00467-010-1471-8","article-title":"Long-term outcome of children with steroid-resistant nephrotic syndrome treated with tacrolimus","volume":"25","author":"Roberti","year":"2010","journal-title":"Pediatr Nephrol"},{"issue":"11","key":"10.1053\/j.ackd.2014.01.010_bib28","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1007\/s00467-012-2228-3","article-title":"Treatment of tacrolimus or cyclosporine A in children with idiopathic nephrotic syndrome","volume":"27","author":"Wang","year":"2012","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"10.1053\/j.ackd.2014.01.010_bib29","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00467-009-1356-x","article-title":"Mycophenolate mofetil in children with steroid\/cyclophosphamide-resistant nephrotic syndrome","volume":"25","author":"de Mello","year":"2010","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"10.1053\/j.ackd.2014.01.010_bib30","doi-asserted-by":"crossref","first-page":"203","DOI":"10.5301\/JN.2011.6327","article-title":"Mycophenolate mofetil in treatment of childhood steroid-resistant nephrotic syndrome","volume":"24","author":"Gargah","year":"2011","journal-title":"J Nephrol"},{"issue":"5","key":"10.1053\/j.ackd.2014.01.010_bib31","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s00467-009-1375-7","article-title":"Mycophenolate mofetil therapy for children with steroid-resistant nephrotic syndrome","volume":"25","author":"Li","year":"2010","journal-title":"Pediatr Nephrol"},{"issue":"7","key":"10.1053\/j.ackd.2014.01.010_bib32","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1007\/s00467-004-1434-z","article-title":"Change of the course of steroid-dependent nephrotic syndrome after rituximab therapy","volume":"19","author":"Benz","year":"2004","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"10.1053\/j.ackd.2014.01.010_bib33","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00467-012-2406-3","article-title":"Long-term outcome of children treated with rituximab for idiopathic nephrotic syndrome","volume":"28","author":"Tellier","year":"2013","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"10.1053\/j.ackd.2014.01.010_bib34","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1093\/ndt\/gfr548","article-title":"Long-term follow-up after rituximab for steroid-dependent idiopathic nephrotic syndrome","volume":"27","author":"Kemper","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ackd.2014.01.010_bib35","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/ndt\/gfr405","article-title":"Rituximab in steroid-dependent idiopathic nephrotic syndrome in childhood\u2013follow-up after CD19 recovery","volume":"27","author":"Sellier-Leclerc","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ackd.2014.01.010_bib36","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000357355","article-title":"Second-line immunosuppressive treatment of childhood nephrotic syndrome: a single-center experience","volume":"4","author":"Kim","year":"2014","journal-title":"Nephron Extra"},{"issue":"8","key":"10.1053\/j.ackd.2014.01.010_bib37","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s00467-008-0814-1","article-title":"Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases","volume":"23","author":"Guigonis","year":"2008","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"10.1053\/j.ackd.2014.01.010_bib38","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.2215\/CJN.09421010","article-title":"Short-term effects of rituximab in children with steroid- and calcineurin-dependent nephrotic syndrome: a randomized controlled trial","volume":"6","author":"Ravani","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ackd.2014.01.010_bib39","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1681\/ASN.2011080775","article-title":"Rituximab in children with resistant idiopathic nephrotic syndrome","volume":"23","author":"Magnasco","year":"2012","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ackd.2014.01.010_bib40","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/ki.1989.227","article-title":"Short and long term effects of antihypertensive therapy in the diabetic rat","volume":"36","author":"Anderson","year":"1989","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ackd.2014.01.010_bib41","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1053\/j.ajkd.2006.10.014","article-title":"Antihypertensive therapy in the presence of proteinuria","volume":"49","author":"Sarafidis","year":"2007","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.ackd.2014.01.010_bib42","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00467-003-1314-y","article-title":"Enalapril dosage in steroid-resistant nephrotic syndrome","volume":"19","author":"Bagga","year":"2004","journal-title":"Pediatr Nephrol"},{"issue":"7","key":"10.1053\/j.ackd.2014.01.010_bib43","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s00467-006-0096-4","article-title":"Effect of fosinopril in children with steroid-resistant idiopathic nephrotic syndrome","volume":"21","author":"Yi","year":"2006","journal-title":"Pediatr Nephrol"},{"issue":"17","key":"10.1053\/j.ackd.2014.01.010_bib44","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJMoa0902066","article-title":"Strict blood-pressure control and progression of renal failure in children","volume":"361","author":"Wuhl","year":"2009","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1053\/j.ackd.2014.01.010_bib45","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.ajpath.2012.12.011","article-title":"Vitamin D down-regulates TRPC6 expression in podocyte injury and proteinuric glomerular disease","volume":"182","author":"Sonneveld","year":"2013","journal-title":"Am J Pathol"},{"issue":"3","key":"10.1053\/j.ackd.2014.01.010_bib46","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00467-012-2341-3","article-title":"Performance of cystatin C-based equations in a pediatric cohort at high risk of kidney injury","volume":"28","author":"Nehus","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"10.1053\/j.ackd.2014.01.010_bib47","series-title":"Toward Precision Medicine: Building a Knowledge Network for Biomedical Research and a New Taxonomy of Disease","author":"Council","year":"2011"}],"container-title":["Advances in Chronic Kidney Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559514000135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559514000135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T10:51:39Z","timestamp":1648464699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1548559514000135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S1548559514000135"],"URL":"https:\/\/doi.org\/10.1053\/j.ackd.2014.01.010","relation":{},"ISSN":["1548-5595"],"issn-type":[{"value":"1548-5595","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}